Cutaneous manifestations in leukemia patients

Seminars in Oncology - Tập 43 - Trang 359-365 - 2016
Michael R. Grunwald1, Megan H. McDonnell1, Raghava Induru1, Jonathan M. Gerber1
1Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC

Tài liệu tham khảo

Bakst, 2011, How I treat extramedullary acute myeloid leukemia, Blood, 118, 3785, 10.1182/blood-2011-04-347229

Cho-Vega, 2008, Leukemia cutis, Am J Clin Pathol, 129, 130, 10.1309/WYACYWF6NGM3WBRT

Longacre, 1993, Leukemia cutis. Analysis of 50 biopsy-proven cases with an emphasis on occurrence in myelodysplastic syndromes, Am J Clin Pathol, 100, 276, 10.1093/ajcp/100.3.276

Agis, 2002, A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis, Ann Hematol, 81, 90, 10.1007/s00277-001-0412-9

Liu, 1973, Autopsy study of granulocytic sarcoma (chloroma) in patients with myelogenous leukemia, Hiroshima-Nagasaki 1949-1969, Cancer, 31, 948, 10.1002/1097-0142(197304)31:4<948::AID-CNCR2820310428>3.0.CO;2-N

Neiman, 1981, Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases, Cancer, 48, 1426, 10.1002/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G

Wiernik, 1970, Granulocytic sarcoma (chloroma), Blood, 35, 361, 10.1182/blood.V35.3.361.361

Wagner, 2012, Leukemia cutis—epidemiology, clinical presentation, and differential diagnoses, J Deutsch Dermatol, 10, 27

Kang, 2013, Clinical characteristics of 75 patients with leukemia cutis, J Korean Med Sci, 28, 614, 10.3346/jkms.2013.28.4.614

Kaddu, 1999, Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria, J Am Acad Dermatol, 40, 966, 10.1016/S0190-9622(99)70086-1

Tobelem, 1980, Acute monoblastic leukemia: a clinical and biologic study of 74 cases, Blood, 55, 71, 10.1182/blood.V55.1.71.71

Watson, 2006, Spectrum of clinical presentation, treatment and prognosis in a series of eight patients with leukaemia cutis, Clin Exp Dermatol, 31, 218, 10.1111/j.1365-2230.2005.02022.x

Paydas, 2000, Leukaemia cutis and leukaemic vasculitis, Br J Dermatol, 143, 773, 10.1046/j.1365-2133.2000.03774.x

Lee, 2009, A case of leukemia cutis at the site of a prior catheter insertion, Ann Dermatol, 21, 193, 10.5021/ad.2009.21.2.193

Kim, 2010, Leukemia cutis limited to the needle puncture sites, J Dermatol, 37, 393, 10.1111/j.1346-8138.2010.00823.x

Meis, 1986, Granulocytic sarcoma in nonleukemic patients, Cancer, 58, 2697, 10.1002/1097-0142(19861215)58:12<2697::AID-CNCR2820581225>3.0.CO;2-R

Pulgar, 2013, Post-bone-marrow-transplant leukemia cutis, Dermatol Online J, 19, 6, 10.5070/D36W07C9WZ

Patel, 2012, Myeloid leukemia cutis in the setting of myelodysplastic syndrome: a crucial dermatological diagnosis, Int J Dermatol, 51, 383, 10.1111/j.1365-4632.2011.05297.x

Tallman, 1993, Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia, J Clin Oncol, 11, 690, 10.1200/JCO.1993.11.4.690

Baer, 1989, Acute myelogenous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986, Cancer, 63, 2192, 10.1002/1097-0142(19890601)63:11<2192::AID-CNCR2820631122>3.0.CO;2-R

Sen, 2000, Increased incidence of trisomy 8 in acute myeloid leukemia with skin infiltration (leukemia cutis), Diagn Mol Pathol, 9, 190, 10.1097/00019606-200012000-00003

Falini, 2007, Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas, Leukemia, 21, 1566, 10.1038/sj.leu.2404699

Ansari-Lari, 2004, FLT3 mutations in myeloid sarcoma, Br J Haematol, 126, 785, 10.1111/j.1365-2141.2004.05124.x

Slomowitz, 2012, Management of extramedullary leukemia as a presentation of acute myeloid leukemia, J Natl Compr Cancer Netw, 10, 1165, 10.6004/jnccn.2012.0120

Ruiz-Arguelles, 2006, t(8;21) (q22;q22) acute myelogenous leukemia in Mexico: a single institution experience, Hematology, 11, 235, 10.1080/10245330600702893

Byrd, 1997, Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461, J Clin Oncol, 15, 466, 10.1200/JCO.1997.15.2.466

Chevallier, 2008, Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC, J Clin Oncol, 26, 4940, 10.1200/JCO.2007.15.6315

Pileri, 2007, Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients, Leukemia, 21, 340, 10.1038/sj.leu.2404491

Bekassy, 1996, Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation, Bone Marrow Transplant, 17, 801

Su, 1994, Clinical, histopathologic, and immunohistochemical correlations in leukemia cutis, Semin Dermatol, 13, 223

Bains, 2010, Current approaches to the diagnosis and treatment of systemic mastocytosis, Ann Allergy Asthma Immunol, 104, 1, 10.1016/j.anai.2009.11.006

Parker, 2000, Hematologic aspects of systemic mastocytosis, Hematol Oncol Clin North Am, 14, 557, 10.1016/S0889-8588(05)70296-3

Dalamaga, 2008, Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients, J Eur Acad Dermatol Venereol, 22, 543, 10.1111/j.1468-3083.2007.02520.x

Kaplan, 2004, Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations, Oral Oncol, 40, 553, 10.1016/j.oraloncology.2003.09.020

van Mook, 2001, Paraneoplastic pemphigus as the initial presentation of chronic lymphocytic leukemia, Ann Oncol, 12, 115, 10.1023/A:1008324929876

Mahajan, 2012, Paraneoplastic pemphigus: a paraneoplastic autoimmune multiorgan syndrome or autoimmune multiorganopathy?, Case Rep Dermatol Med, 2012, 207126

Helm, 1993, Paraneoplastic pemphigus. A distinct autoimmune vesiculobullous disorder associated with neoplasia, Oral Surg Oral Med Oral Pathol, 75, 209, 10.1016/0030-4220(93)90095-L

Anhalt, 1990, Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia, N Engl J Med, 323, 1729, 10.1056/NEJM199012203232503

Moustafa, 2013, A skin rash and what lies beneath: paraneoplastic pemphigus, an atypical presentation of follicular cell lymphoma, Am J Hematol, 88, 822, 10.1002/ajh.23471

Limdiwala, 2014, Sweet’s syndrome, Ind J Dental Res, 25, 401, 10.4103/0970-9290.138358

Lear, 1997, Neutrophilic dermatoses: pyoderma gangrenosum and Sweet’s syndrome, Postgrad Med J, 73, 65, 10.1136/pgmj.73.856.65

Yamauchi, 2003, Successful treatment of pyoderma gangrenosum that developed in a patient with myelodysplastic syndrome, J Infect Chemother, 9, 268, 10.1007/s10156-003-0254-6

Rochet, 2013, Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients, J Am Acad Dermatol, 69, 557, 10.1016/j.jaad.2013.06.023

Usul Afsar, 2013, Sweet syndrome in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma: curious lymphocyte/neutrophil fluctuations, Turk J Haematol, 30, 413, 10.4274/Tjh.2012.0055

Kazmi, 2015, Characteristics of Sweet syndrome in patients with acute myeloid leukemia, Clin Lymphoma Myeloma Leuk, 15, 358, 10.1016/j.clml.2014.12.009

Alkayem, 2014, A case report of hairy cell leukemia presenting concomitantly with sweet syndrome, Case Rep Med, 2014, 823286, 10.1155/2014/823286

Asai, 2001, Pyoderma gangrenosum associated with biphenotypic acute leukemia, J Am Acad Dermatol, 44, 530, 10.1067/mjd.2001.112377

Beele, 2000, Pyoderma gangrenosum as an early revelator of acute leukemia, Dermatology, 200, 176, 10.1159/000018360

Rogalski, 2003, Bullous pyoderma gangrenosum complicated by disseminated intravascular coagulation with subsequent myelodysplastic syndrome (chronic myelomonocytic leukemia), J Dermatol, 30, 59

Loricera, 2013, The spectrum of paraneoplastic cutaneous vasculitis in a defined population: incidence and clinical features, Medicine, 92, 331, 10.1097/MD.0000000000000009

Farah, 2010, Prevalence and prognostic value of cutaneous manifestations in patients with myelodysplastic syndrome, J Eur Acad Dermatol Venereol, 24, 1171, 10.1111/j.1468-3083.2010.03614.x

Ishida, 2014, Skin erythema with leukocytoclastic vasculitis and elastophagocytosis as the presenting features of an underlying myelodysplastic syndrome, Int J Clin Exp Pathol, 7, 835

Gaertner, 2012, Cutaneous granulomatous vasculitis associated with chronic lymphocytic leukemia: case report and review of literature of a rare entity, Dermatol Online J, 18, 12, 10.5070/D37111D8SJ

Perez-Alamino, 2014, Non-infectious cryoglobulinemia vasculitis (CryoVas): update on clinical and therapeutic approach, Curr Rheumatol Rep, 16, 420, 10.1007/s11926-014-0420-0

Rabhi, 2007, Acquired ichthyosis disclosing non-Hodgkin’s malignant lymphoma, Intern Med, 46, 397, 10.2169/internalmedicine.46.1712

Berrady, 2012, [Acquired ichthyosis and haematological malignancies: five cases], Ann Dermatol Venereol, 139, 9, 10.1016/j.annder.2011.10.394

Dilek, 1998, Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia, Bone Marrow Transplant, 21, 1159, 10.1038/sj.bmt.1701240

Spelman, 1996, Acquired ichthyosis in bone marrow transplant recipients, J Am Acad Dermatol, 35, 17, 10.1016/S0190-9622(96)90489-2

Word, 2014, Beware of underlying malignancy: acquired ichthyosis, Am J Med, 127, 202, 10.1016/j.amjmed.2013.12.009

Yosipovitch, 2010, Chronic pruritus: a paraneoplastic sign, Dermatol Ther, 23, 590, 10.1111/j.1529-8019.2010.01366.x

Lotts, 2014, Research in practice: substance P antagonism in chronic pruritus, J Deutsch Dermatol Gesellschaft, 12, 557

Stander, 2010, Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy, PloS One, 5, e10968, 10.1371/journal.pone.0010968

Gunal, 2004, Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial, Nephrol Dial Transplant, 19, 3137, 10.1093/ndt/gfh496

Manenti, 2005, Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation, J Nephrol, 18, 86

Chandran, 2013, Concurrent presentation of Hodgkin lymphoma and multiple myeloma, Case Rep Hematol, 2013, 398769

Grille, 2013, [Cytarabine and skin reactions in acute myeloid leukemia], Medicina, 73, 535

Susser, 1999, Mucocutaneous reactions to chemotherapy, J Am Acad Dermatol, 40, 367, 10.1016/S0190-9622(99)70488-3

Cetkovska, 2002, High-dose cytosine arabinoside-induced cutaneous reactions, J Eur Acad Dermatol Venereol, 16, 481, 10.1046/j.1468-3083.2002.00395.x

Hurt, 1990, Eccrine squamous syringometaplasia. A cutaneous sweat gland reaction in the histologic spectrum of ’chemotherapy-associated eccrine hidradenitis’ and ’neutrophilic eccrine hidradenitis’, Arch Dermatol, 126, 73, 10.1001/archderm.1990.01670250079013

Thorisdottir, 1993, Neutrophilic eccrine hidradenitis, J Am Acad Dermatol, 28, 775, 10.1016/0190-9622(93)70090-G

Yokel, 1993, Mucocutaneous complications of anti-neoplastic therapy, 1800

Williams, 1999, Chemotherapy-induced inflammation in seborrheic keratoses mimicking disseminated herpes zoster, J Am Acad Dermatol, 40, 643, 10.1016/S0190-9622(99)70455-X

Brown, 1991, Treatment of cytarabine acral erythema with corticosteroids, J Am Acad Dermatol, 24, 1023, 10.1016/S0190-9622(08)80126-0

Marigny, 2005, Particular cutaneous side effects with etoposide-containing courses: is VP16 or etoposide phosphate responsible?, Cancer Chemother Pharmacol, 55, 244, 10.1007/s00280-004-0858-2

Blume, 1987, Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplant in patients with advanced hematologic malignancies, Blood, 69, 1015, 10.1182/blood.V69.4.1015.1015

Schmitz, 1988, Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplant in advanced leukemias, Blood, 72, 1567, 10.1182/blood.V72.5.1567.1567

Bostrom, 1990, Bone marrow transplant for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide, Bone Marrow Transplant, 5, 83

Murphy, 1993, Dose-related cutaneous toxicities with etoposide, Cancer, 71, 3153, 10.1002/1097-0142(19930515)71:10<3153::AID-CNCR2820711042>3.0.CO;2-#

Zhang, 2014, Enhanced skin toxicity associated with the combination of clofarabine plus cytarabine for the treatment of acute leukemia, Cancer Chemother Pharmacol, 74, 303, 10.1007/s00280-014-2504-y

von Gruenigen, 2010, A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gynecologic oncology patients, Cancer, 116, 4735, 10.1002/cncr.25262

Kang, 2010, Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study, J Clin Oncol, 28, 3824, 10.1200/JCO.2010.29.1807

Latif, 2010, Increased mast cell density in capecitabine-induced hand-foot syndrome: a new pathologic finding, J Drugs Dermatol, 9, 268

Sil, 2014, Sorafenib-induced hand-foot syndrome in a patient of renal cell carcinoma, Ind J Parmacol, 46, 334

Robert, 2009, Dermatologic symptoms associated with the multikinase inhibitor sorafenib, J Am Acad Dermatol, 60, 299, 10.1016/j.jaad.2008.06.034

Mays, 2006, Cutaneous fungal infections in the oncology patient: recognition and management, Am J Clin Dermatol, 7, 31, 10.2165/00128071-200607010-00004

Caira, 2015, Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study), Haematologica, 100, 284, 10.3324/haematol.2014.113399

Nucci, 2014, How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach, Blood, 124, 3858, 10.1182/blood-2014-04-516211

Vaiman, 2015, Ecthyma gangrenosum and ecthyma-like lesions: review article, Eur J Clin Microbiol Infect Dis, 34, 633, 10.1007/s10096-014-2277-6

Tunkel, 2002, Infections caused by viridans streptococci in patients with neutropenia, Clin Infect Dis, 34, 1524, 10.1086/340402

Bochud, 1994, Bacteremia due to viridans streptococci in neutropenic patients: a review, Am J Med, 97, 256, 10.1016/0002-9343(94)90009-4

Thông tin
Thông tin xuất bản

Seminars in Oncology

Tập 43

359-365

Thông tin tác giả